BERGER FRANKLIN M
Insider CIK 1273885 · SGEN Director · FPRX Director · TOCA Director · IMDZ Director · PTI Director · BCEL Director · AVIR Director · EPIX Director · KZR Director · RAIN Director · RTSN Director · BTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RTSN Retension Pharmaceuticals, | C Conversion deriv | 2026-10-13 | 2026-10-13 | 12,517 | — | — | 0 | SEC↗ |
| RTSN Retension Pharmaceuticals, | P Buy | 2026-10-13 | 2026-10-13 | 10,000 | $12.00 | $120.0K | 10,000 | SEC↗ |
| RTSN Retension Pharmaceuticals, | C Conversion | 2026-10-13 | 2026-10-13 | 12,517 | — | — | 12,517 | SEC↗ |
| RTSN Retension Pharmaceuticals, | A Award deriv | 2026-10-08 | 2026-10-08 | 5,636 | — | $0 | 5,636 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 26,700 | — | $0 | 26,700 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-06-18 | 2026-06-23 | 29,600 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 37,700 | — | $0 | 37,700 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-06-18 | 2026-06-23 | 29,600 | — | $0 | 536,097 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 3,500 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 2,600 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 2,600 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | U Tender | 2026-05-11 | 2026-05-11 | 89,069 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | D To issuer | 2025-10-09 | 2025-10-15 | 784,404 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 29,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 41,200 | — | $0 | 41,200 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 506,497 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2025-06-18 | 2025-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2025-01-16 | 2025-01-17 | 10,000 | $3.36 | $33.6K | 476,897 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2025-01-16 | 2025-01-17 | 10,000 | $3.36 | $33.6K | 476,897 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2025-01-15 | 2025-01-17 | 15,000 | $3.19 | $47.9K | 466,897 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2025-01-15 | 2025-01-17 | 15,000 | $3.19 | $47.9K | 466,897 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 359,606 | $2.85 | $1.02M | 451,897 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 41,200 | — | $0 | 41,200 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 29,600 | — | $0 | 29,600 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-06-16 | 2024-06-18 | 33,150 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-06-16 | 2024-06-18 | 33,150 | — | $0 | 811,503 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 24,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-26 | 2024-01-26 | 1,005,207 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | P Buy | 2023-11-21 | 2023-11-22 | 23,259 | $5.73 | $133.3K | 784,404 | SEC↗ |
| EPIX ESSA Pharma Inc. | P Buy | 2023-11-03 | 2023-11-16 | 16,471 | $5.99 | $98.7K | 760,875 | SEC↗ |
| EPIX ESSA Pharma Inc. | P Buy | 2023-11-02 | 2023-11-16 | 60,000 | $5.35 | $321.0K | 744,404 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 26,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 33,150 | — | $0 | 33,150 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 46,750 | — | $0 | 46,750 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-21 | 2023-01-05 | 34,334 | $2.42 | $83.1K | 684,404 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-21 | 2023-01-05 | 37,889 | $2.41 | $91.3K | 718,738 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-20 | 2023-01-05 | 43,617 | $2.53 | $110.4K | 756,627 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-16 | 2023-01-05 | 50,000 | $2.67 | $133.5K | 800,244 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-15 | 2023-01-05 | 32,000 | $2.90 | $92.8K | 900,244 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-15 | 2023-01-05 | 50,000 | $2.86 | $143.0K | 850,244 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2022-12-14 | 2023-01-05 | 25,000 | $3.00 | $75.0K | 932,244 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-22 | 2022-11-23 | 77,000 | $8.27 | $636.8K | 1,005,207 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-21 | 2022-11-23 | 45,000 | $7.80 | $351.0K | 928,207 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2022-11-14 | 2022-11-15 | 16,166 | $5.16 | $83.4K | 778,353 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2022-11-11 | 2022-11-15 | 25,500 | $5.15 | $131.3K | 794,519 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-08 | 2022-11-14 | 42,881 | $5.83 | $250.0K | 883,207 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 61,264 | — | $0 | 61,264 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 26,000 | — | $0 | 26,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-06-01 | 2022-08-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2022-03-21 | 2022-03-22 | 20,000 | $14.77 | $295.4K | 890,691 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2022-03-18 | 2022-03-22 | 45,000 | $17.00 | $765.0K | 870,691 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2022-03-18 | 2022-03-22 | 15,000 | $15.96 | $239.4K | 825,691 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise deriv | 2021-09-22 | 2021-09-23 | 8,896 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise | 2021-09-22 | 2021-09-23 | 8,896 | $5.60 | $49.8K | 810,691 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise deriv | 2021-09-21 | 2021-09-23 | 8,896 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise deriv | 2021-09-21 | 2021-09-23 | 8,896 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise | 2021-09-21 | 2021-09-23 | 8,896 | $7.63 | $67.9K | 801,795 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise | 2021-09-21 | 2021-09-23 | 8,896 | $5.91 | $52.6K | 792,899 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-21 | 2021-09-23 | 3,786 | $14.30 | $54.1K | 840,326 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 26,000 | — | $0 | 26,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-06-18 | 2021-06-21 | 34,025 | — | $0 | 34,025 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 578,397 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 189,998 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 175,939 | — | $0 | 300,939 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 535,601 | — | $0 | 836,540 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 120,000 | $17.00 | $2.04M | 120,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 5,000 | $15.78 | $78.9K | 125,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 20,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 5,000 | $38.00 | $190.0K | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | P Buy | 2021-02-22 | 2021-03-04 | 57,000 | $27.00 | $1.54M | 957,244 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise deriv | 2020-12-03 | 2021-01-11 | 6,534 | — | $0 | 2,966 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise deriv | 2020-12-03 | 2021-01-11 | 1,716 | — | $0 | 784 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise deriv | 2020-12-03 | 2021-01-11 | 25,000 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise deriv | 2020-12-03 | 2021-01-11 | 6,773 | — | $0 | 18,227 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise deriv | 2020-12-03 | 2021-01-11 | 2,184 | — | $0 | 2,816 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise | 2020-12-03 | 2021-01-11 | 2,184 | $3.81 | $8.3K | 868,471 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise | 2020-12-03 | 2021-01-11 | 25,000 | $3.23 | $80.8K | 893,471 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise | 2020-12-03 | 2021-01-11 | 6,773 | $4.67 | $31.6K | 900,244 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise | 2020-12-03 | 2021-01-11 | 6,534 | $4.00 | $26.1K | 866,287 | SEC↗ |
| EPIX ESSA Pharma Inc. | M Exercise | 2020-12-03 | 2021-01-11 | 1,716 | $4.00 | $6.9K | 859,753 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 132,014 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 400,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 35,474 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 60,540 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 131,578 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2020-11-03 | 2020-11-03 | 41,666 | $24.00 | $1000.0K | 820,019 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-03 | 759,606 | — | $0 | 778,353 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2020-10-29 | 2020-10-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2020-06-29 | 2020-07-01 | 17,400 | — | $0 | 17,400 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2020-06-11 | 2020-06-11 | 100,000 | $5.50 | $550.0K | 784,003 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-06-10 | 2020-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-05-14 | 2020-05-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2020-02-04 | 2020-02-05 | 120,846 | $2.60 | $314.2K | 684,003 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | S Sale | 2019-12-03 | 2019-12-04 | 47,890 | $4.00 | $191.6K | 5,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | S Sale | 2019-12-02 | 2019-12-04 | 32,090 | $3.92 | $125.8K | 52,890 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2019-06-27 | 2019-07-01 | 15,300 | — | $0 | 15,300 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 8,896 | — | $0 | 8,896 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 36,036 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 13,164 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 26,115 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion | 2019-06-24 | 2019-06-24 | 75,315 | — | $0 | 97,808 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 10,000 | — | $0 | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer | 2019-04-02 | 2019-04-04 | 75,000 | $5.85 | $438.8K | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | A Award deriv | 2019-01-03 | 2019-01-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2018-10-26 | 2018-10-26 | 40,000 | $6.75 | $270.0K | 40,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 262,907 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 197,076 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2018-06-25 | 2018-06-27 | 50,000 | $15.00 | $750.0K | 563,157 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 197,076 | — | $0 | 513,157 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 262,907 | — | $0 | 316,081 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2018-06-15 | 2018-06-19 | 15,300 | — | $0 | 15,300 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2018-01-04 | 2018-01-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2017-12-18 | 2017-12-19 | 60,000 | $5.00 | $300.0K | 266,162 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2017-10-30 | 2017-11-01 | 25,000 | $4.58 | $114.5K | 75,000 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2017-10-25 | 2017-10-26 | 25,000 | $4.26 | $106.5K | 50,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2017-08-03 | 2017-08-07 | 63,663 | — | $0 | 63,663 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TOCA Tocagen Inc | J Other | 2017-04-19 | 2017-04-21 | 25,335 | $10.00 | $253.3K | 25,335 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2017-04-12 | 2017-04-12 | 7,246 | — | $0 | 7,246 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2017-01-04 | 2017-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-16 | 2016-12-19 | 14,000 | $11.52 | $161.3K | 206,162 | SEC↗ |
| IMDZ Immune Design Corp. | S Sale | 2016-12-16 | 2016-12-20 | 50,000 | $6.55 | $327.5K | 25,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-15 | 2016-12-19 | 26,000 | $10.99 | $285.7K | 192,162 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-09-14 | 2016-09-15 | 69,230 | $13.00 | $900.0K | 166,162 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-05-19 | 2016-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2016-04-22 | 2016-04-26 | 2,000 | $49.90 | $99.8K | 81,980 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2016-04-22 | 2016-04-26 | 3,000 | $49.18 | $147.5K | 84,980 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2016-04-19 | 2016-04-21 | 4,000 | $47.23 | $188.9K | 77,890 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2016-04-19 | 2016-04-21 | 2,090 | $46.74 | $97.7K | 79,980 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 777,604 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion | 2016-02-17 | 2016-02-17 | 71,932 | — | $0 | 71,932 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-02-17 | 2016-02-17 | 25,000 | $8.00 | $200.0K | 96,932 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2016-02-10 | 2016-02-12 | 45,760 | — | $0 | 45,760 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2016-01-04 | 2016-01-06 | 9,300 | — | $0 | 9,300 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-09-22 | 2015-09-24 | 12,500 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-09-22 | 2015-09-24 | 12,500 | $12.70 | $158.8K | 73,890 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-09-02 | 2015-09-04 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-09-02 | 2015-09-04 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-09-02 | 2015-09-04 | 4,065 | $8.49 | $34.5K | 57,325 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-09-02 | 2015-09-04 | 4,065 | $7.26 | $29.5K | 61,390 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-07-01 | 2015-07-02 | 2,439 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-07-01 | 2015-07-02 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-07-01 | 2015-07-02 | 2,439 | $6.89 | $16.8K | 53,260 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-07-01 | 2015-07-02 | 4,065 | $5.54 | $22.5K | 50,821 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-06-17 | 2015-06-19 | 9,756 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-06-17 | 2015-06-19 | 9,756 | $6.89 | $67.2K | 46,756 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-06-12 | 2015-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2015-04-21 | 2015-04-21 | 25,000 | $26.50 | $662.5K | 75,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2015-01-28 | 2015-01-29 | 25,000 | $27.03 | $675.8K | 37,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2015-01-15 | 2015-01-16 | 5,049 | $25.76 | $130.1K | 12,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2015-01-14 | 2015-01-16 | 5,000 | $26.58 | $132.9K | 6,951 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2015-01-07 | 2015-01-09 | 9,300 | — | $0 | 9,300 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2014-11-28 | 2014-12-02 | 1,100 | $21.04 | $23.1K | 1,951 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2014-11-28 | 2014-12-02 | 851 | $21.04 | $17.9K | 851 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 50,000 | $12.00 | $600.0K | 50,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-05-16 | 2014-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2014-02-21 | 2014-02-25 | 7,500 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2014-02-21 | 2014-02-25 | 7,500 | $12.76 | $95.7K | 204,720 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2013-08-28 | 2013-08-30 | 10,000 | — | $0 | 7,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2013-08-28 | 2013-08-30 | 10,000 | $12.76 | $127.6K | 197,220 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2013-08-20 | 2013-08-22 | 500 | $3.71 | $1.9K | 500 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2013-07-01 | 2013-07-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2013-05-17 | 2013-05-21 | 8,750 | $36.70 | $321.1K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2013-05-17 | 2013-05-21 | 3,500 | — | $0 | 187,220 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2012-08-23 | 2012-08-27 | 10,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2012-08-23 | 2012-08-27 | 10,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2012-08-23 | 2012-08-27 | 10,000 | $10.08 | $100.8K | 183,720 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2012-08-23 | 2012-08-27 | 10,000 | $10.20 | $102.0K | 173,720 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2012-05-18 | 2012-05-22 | 17,500 | $20.06 | $351.1K | 17,500 | SEC↗ |